Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
ADC Therapeutics SA (ADCT) had Weighted-Average Shares Outstanding (Diluted) of 155.02M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$19.25M |
|
$-16.57M |
|
$2.35M |
|
$16.90M |
|
$44.66M |
|
$-25.41M |
|
$8.85M |
|
$-16.57M |
|
$-16.57M |
|
$-16.57M |
|
$-16.57M |
|
$-16.57M |
|
$-16.57M |
|
$-25.41M |
|
$-25.41M |
|
155.02M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
155.02M |
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$261.71M |
|
-- |
|
$17.67M |
|
$279.38M |
|
$86.33M |
|
$110.44M |
|
$421.25M |
|
$507.58M |
|
$-228.20M |
|
$-228.21M |
|
$-228.21M |
|
127.44M |
|
| Cash Flow Statement Financials | |
$-41.52M |
|
$-0.03M |
|
$-0.68M |
|
$261.34M |
|
$219.11M |
|
$-42.23M |
|
$6.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.03 |
|
-- |
|
-- |
|
-0.94 |
|
-0.51 |
|
87.80% |
|
-132.03% |
|
-132.03% |
|
-- |
|
-86.06% |
|
-86.06% |
|
$-41.55M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.48 |
|
0.69 |
|
131.09 |
|
7.26% |
|
7.26% |
|
-5.93% |
|
14.07% |
|
$-1.79 |
|
$-0.27 |
|
$-0.27 |
|